BfArM — authorised 17 July 2015
- Marketing authorisation holder: Merck Sharp & Dohme Limited
- Status: approved
BfArM authorised Keytruda on 17 July 2015
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. BfArM authorised it on 17 July 2015.
Merck Sharp & Dohme Limited holds the German marketing authorisation.